The list of squandered opportunities this board and management will take quite some time to go through. I sincerely hope that this is one of many right decision that they can achieve.
It will be interesting how the dargues on site processing application will play out. There seems to be more concerns (naturally) about it than positive.
Whilst I am similarly impressed that they flew some people to henty for fact finding, there aren't much follow up news.
I Think the major worry over the few quarters is the remediation work at Bendigo. There is no clear guide on what exactly is expected of the rehabilitation. As our cash generating period draws to a close, this could really be a drag on cash.
Anyone habe any idea about this?
- Forums
- ASX - By Stock
- UML
- Ann: December 2014 Quarterly Report
Ann: December 2014 Quarterly Report, page-24
-
- There are more pages in this discussion • 5 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add UML (ASX) to my watchlist
Currently unlisted public company.
The Watchlist
RCE
RECCE PHARMACEUTICALS LTD
James Graham, CEO
James Graham
CEO
Previous Video
Next Video
SPONSORED BY The Market Online